According to Turnstone Biologics's latest financial reports the company's current EPS (TTM) is -0,96ย โฌ. In 2022 the company made an earnings per share (EPS) of -1,32ย โฌ a decrease over its 2021 EPS that were of 1,42ย โฌ.